Form 4 for AEHR AEHR TEST SYSTEMS
Accepted 2021-09-30 00:00:00 ET · period of report 2021-09-28 · accession 0001654954-21-010629 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-30 | 2021-09-28+ | AEHR | SPINK KENNETH B. | CFO, VP of Fin | M - OptEx | $2.40 | +136.9K | 135.6K | New | +$328.2K |
| D | 2021-09-30 | 2021-09-28 | AEHR | SPINK KENNETH B. | CFO, VP of Fin | S - Sale+OE | $14.13 | -133.9K | 86.0K | -61% | -$1.89M |
| DM | 2021-09-30 | 2021-09-28+ | AEHR | SPINK KENNETH B. | CFO, VP of Fin | M - OptEx | $0.00 | -136.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-29 | M | A | 25,000 | $1.64 | 129,029 | D | — | — | (F3) The amount reported includes shares subject to unvested restricted stock units. |
| 2 | Common | Common Stock | 2021-09-29 | M | A | 18,000 | $1.68 | 104,029 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-28 | S | D | 133,914 | $14.13 | 86,029 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2021. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.50 to $14.79, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. |
| 4 | Common | Common Stock | 2021-09-28 | M | A | 30,989 | $2.40 | 219,943 | D | — | — | |
| 5 | Common | Common Stock | 2021-09-28 | M | A | 24,400 | $3.93 | 188,954 | D | — | — | |
| 6 | Common | Common Stock | 2021-09-28 | M | A | 29,000 | $2.30 | 164,554 | D | — | — | |
| 7 | Common | Common Stock | 2021-09-28 | M | A | 9,500 | $2.10 | 135,554 | D | — | — | |
| 8 | Derivative | Incentive Stock Option (right to buy) | 2021-09-29 | M | D | 25,000 | $0.00 | 25,000 | D | $1.64 · 2019-08-16 to 2026-07-16 | 25,000 Common Stock | (F4) One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |
| 9 | Derivative | Incentive Stock Option (right to buy) | 2021-09-28 | M | D | 30,989 | $0.00 | 11,511 | D | $2.40 · 2018-09-17 to 2025-08-17 | 30,989 Common Stock | (F4) One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |
| 10 | Derivative | Incentive Stock Option (right to buy) | 2021-09-28 | M | D | 29,000 | $0.00 | 0 | D | $2.30 · 2015-10-09 to 2022-09-09 | 29,000 Common Stock | (F4) One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |
| 11 | Derivative | Incentive Stock Option (right to buy) | 2021-09-28 | M | D | 24,400 | $0.00 | 0 | D | $3.93 · 2017-08-11 to 2024-07-11 | 24,400 Common Stock | (F4) One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |
| 12 | Derivative | Incentive Stock Option (right to buy) | 2021-09-28 | M | D | 9,500 | $0.00 | 0 | D | $2.10 · 2015-05-21 to 2022-04-21 | 9,500 Common Stock | (F4) One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |
| 13 | Derivative | Incentive Stock Option (right to buy) | 2021-09-29 | M | D | 18,000 | $0.00 | 0 | D | $1.68 · 2016-08-25 to 2023-07-25 | 18,000 Common Stock | (F4) One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |